PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,033,000 | +176.2% | 96,000 | +2894.4% | 0.15% | +166.1% |
| Q2 2015 | $374,000 | -53.9% | 3,206 | -6.8% | 0.06% | -50.9% |
| Q1 2015 | $812,000 | +83.7% | 3,441 | +47.3% | 0.11% | +78.1% |
| Q4 2014 | $442,000 | -20.6% | 2,336 | 0.0% | 0.06% | -24.7% |
| Q3 2014 | $557,000 | +76.8% | 2,336 | -51.0% | 0.08% | +84.8% |
| Q2 2014 | $315,000 | -32.1% | 4,770 | +7.0% | 0.05% | -32.4% |
| Q1 2014 | $464,000 | -88.0% | 4,459 | -88.1% | 0.07% | -87.6% |
| Q4 2013 | $3,869,000 | +1132.2% | 37,367 | +538.0% | 0.55% | +1039.6% |
| Q3 2013 | $314,000 | +26.6% | 5,857 | +4.7% | 0.05% | +9.1% |
| Q2 2013 | $248,000 | – | 5,596 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |